(1->4)-beta-D-glucan multiple interactions ISO Scara5 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SCARA5 mRNA CTD PMID:36331819 1,2-dichloroethane decreases expression ISO Scara5 (Mus musculus) 6480464 ethylene dichloride results in decreased expression of SCARA5 mRNA CTD PMID:28960355 17beta-estradiol decreases expression ISO Scara5 (Mus musculus) 6480464 Estradiol results in decreased expression of SCARA5 mRNA CTD PMID:19484750 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO Scara5 (Mus musculus) 6480464 2 more ... CTD PMID:30294300 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Scara5 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of SCARA5 mRNA CTD PMID:19933214 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of SCARA5 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of SCARA5 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Scara5 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of SCARA5 mRNA CTD PMID:28213091 and PMID:33956508 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Scara5 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of SCARA5 mRNA CTD PMID:28922406 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Scara5 (Mus musculus) 6480464 [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of SCARA5 mRNA CTD PMID:25975270 3,3',4,4',5-pentachlorobiphenyl increases expression EXP 6480464 3 more ... CTD PMID:32119087 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO SCARA5 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of SCARA5 mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol decreases expression ISO SCARA5 (Homo sapiens) 6480464 bisphenol S results in decreased expression of SCARA5 mRNA CTD PMID:33476716 4,4'-sulfonyldiphenol increases expression ISO Scara5 (Mus musculus) 6480464 bisphenol S results in increased expression of SCARA5 mRNA CTD PMID:30951980 5-aza-2'-deoxycytidine affects expression ISO SCARA5 (Homo sapiens) 6480464 Decitabine affects the expression of SCARA5 mRNA CTD PMID:23300844 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of SCARA5 mRNA CTD PMID:30047161 6-propyl-2-thiouracil multiple interactions ISO Scara5 (Mus musculus) 6480464 [Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of SCARA5 mRNA CTD PMID:36706583 acrylamide affects expression EXP 6480464 Acrylamide affects the expression of SCARA5 mRNA CTD PMID:28959563 acrylamide decreases expression ISO Scara5 (Mus musculus) 6480464 Acrylamide results in decreased expression of SCARA5 mRNA CTD PMID:35032568 aflatoxin B1 affects methylation ISO SCARA5 (Homo sapiens) 6480464 Aflatoxin B1 affects the methylation of SCARA5 intron CTD PMID:30157460 amitrole decreases expression EXP 6480464 Amitrole results in decreased expression of SCARA5 mRNA CTD PMID:30047161 arsane affects methylation ISO SCARA5 (Homo sapiens) 6480464 Arsenic affects the methylation of SCARA5 gene CTD PMID:25304211 arsenic atom affects methylation ISO SCARA5 (Homo sapiens) 6480464 Arsenic affects the methylation of SCARA5 gene CTD PMID:25304211 atrazine affects methylation EXP 6480464 Atrazine affects the methylation of SCARA5 gene CTD PMID:28931070 benzo[a]pyrene decreases expression ISO Scara5 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of SCARA5 mRNA CTD PMID:19770486 and PMID:22610609 benzo[a]pyrene affects methylation ISO SCARA5 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of SCARA5 intron CTD PMID:30157460 benzo[a]pyrene increases methylation ISO SCARA5 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of SCARA5 exon and Benzo(a)pyrene results in increased methylation of SCARA5 promoter CTD PMID:27901495 benzo[a]pyrene increases expression ISO Scara5 (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of SCARA5 mRNA CTD PMID:27195522 benzo[e]pyrene affects methylation ISO SCARA5 (Homo sapiens) 6480464 benzo(e)pyrene affects the methylation of SCARA5 intron CTD PMID:30157460 bis(2-ethylhexyl) phthalate multiple interactions ISO Scara5 (Mus musculus) 6480464 Diethylhexyl Phthalate inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in increased expression of SCARA5 mRNA] CTD PMID:33484791 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of SCARA5 mRNA CTD PMID:25181051 bisphenol A multiple interactions ISO SCARA5 (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of SCARA5 gene CTD PMID:31601247 bisphenol A affects methylation ISO SCARA5 (Homo sapiens) 6480464 bisphenol A affects the methylation of SCARA5 gene CTD PMID:31601247 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of SCARA5 mRNA CTD PMID:34947998 bisphenol A increases expression ISO Scara5 (Mus musculus) 6480464 bisphenol A results in increased expression of SCARA5 mRNA CTD PMID:30951980 and PMID:33221593 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of SCARA5 gene CTD PMID:28505145 bisphenol F increases expression ISO Scara5 (Mus musculus) 6480464 bisphenol F results in increased expression of SCARA5 mRNA CTD PMID:30951980 bisphenol F decreases expression ISO Scara5 (Mus musculus) 6480464 bisphenol F results in decreased expression of SCARA5 mRNA CTD PMID:36706583 buta-1,3-diene decreases expression ISO Scara5 (Mus musculus) 6480464 1 and 3-butadiene results in decreased expression of SCARA5 mRNA CTD PMID:29038090 cadmium atom multiple interactions ISO Scara5 (Mus musculus) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SCARA5 mRNA CTD PMID:37325564 cadmium dichloride multiple interactions ISO Scara5 (Mus musculus) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of SCARA5 mRNA CTD PMID:37325564 cantharidin decreases expression ISO Scara5 (Mus musculus) 6480464 Cantharidin results in decreased expression of SCARA5 mRNA CTD PMID:36907384 carbon nanotube increases expression ISO Scara5 (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25620056 chloroprene increases expression ISO Scara5 (Mus musculus) 6480464 Chloroprene results in increased expression of SCARA5 mRNA CTD PMID:23125180 choline multiple interactions ISO Scara5 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SCARA5 mRNA CTD PMID:20938992 ciguatoxin CTX1B affects expression ISO Scara5 (Mus musculus) 6480464 Ciguatoxins affects the expression of SCARA5 mRNA CTD PMID:18353800 cisplatin affects expression ISO SCARA5 (Homo sapiens) 6480464 Cisplatin affects the expression of SCARA5 mRNA CTD PMID:23300844 copper atom decreases expression EXP 6480464 Copper results in decreased expression of SCARA5 mRNA CTD PMID:30556269 copper(0) decreases expression EXP 6480464 Copper results in decreased expression of SCARA5 mRNA CTD PMID:30556269 crocidolite asbestos decreases expression ISO Scara5 (Mus musculus) 6480464 Asbestos and Crocidolite results in decreased expression of SCARA5 mRNA CTD PMID:29279043 cyclosporin A increases expression ISO Scara5 (Mus musculus) 6480464 Cyclosporine results in increased expression of SCARA5 mRNA CTD PMID:25270620 deoxynivalenol decreases expression ISO SCARA5 (Homo sapiens) 6480464 deoxynivalenol results in decreased expression of SCARA5 mRNA CTD PMID:26763390 dexamethasone increases expression ISO Scara5 (Mus musculus) 6480464 Dexamethasone results in increased expression of SCARA5 mRNA CTD PMID:22733784 dexamethasone multiple interactions ISO SCARA5 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of SCARA5 mRNA CTD PMID:28628672 dexamethasone increases expression ISO SCARA5 (Homo sapiens) 6480464 Dexamethasone results in increased expression of SCARA5 mRNA CTD PMID:25047013 dibutyl phthalate decreases expression ISO Scara5 (Mus musculus) 6480464 Dibutyl Phthalate results in decreased expression of SCARA5 mRNA CTD PMID:21266533 dichloroacetic acid decreases expression ISO Scara5 (Mus musculus) 6480464 Dichloroacetic Acid results in decreased expression of SCARA5 mRNA CTD PMID:28962523 diclofenac increases expression ISO Scara5 (Mus musculus) 6480464 Diclofenac results in increased expression of SCARA5 mRNA CTD PMID:26934552 diiodine multiple interactions ISO Scara5 (Mus musculus) 6480464 [Propylthiouracil co-treated with Iodine deficiency] results in decreased expression of SCARA5 mRNA CTD PMID:36706583 dioxygen multiple interactions EXP 6480464 [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of SCARA5 mRNA CTD PMID:33729688 diuron decreases expression EXP 6480464 Diuron results in decreased expression of SCARA5 mRNA CTD PMID:25152437 doxorubicin decreases expression ISO SCARA5 (Homo sapiens) 6480464 Doxorubicin results in decreased expression of SCARA5 mRNA CTD PMID:29803840 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of SCARA5 mRNA CTD PMID:29391264 Erionite decreases expression ISO Scara5 (Mus musculus) 6480464 erionite results in decreased expression of SCARA5 mRNA CTD PMID:29279043 folic acid multiple interactions ISO Scara5 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SCARA5 mRNA CTD PMID:20938992 fulvestrant multiple interactions ISO SCARA5 (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in decreased methylation of SCARA5 gene CTD PMID:31601247 furan decreases expression EXP 6480464 furan results in decreased expression of SCARA5 mRNA CTD PMID:25539665 furan increases expression EXP 6480464 furan results in increased expression of SCARA5 mRNA CTD PMID:27387713 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of SCARA5 mRNA CTD PMID:33387578 glycidol increases expression EXP 6480464 glycidol results in increased expression of SCARA5 mRNA CTD PMID:24395379 hexane-1,6-diamine increases abundance ISO SCARA5 (Homo sapiens) 6480464 SCARA5 gene modified form results in increased abundance of 1 and 6-diaminohexane CTD PMID:25445006 indometacin multiple interactions ISO SCARA5 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of SCARA5 mRNA CTD PMID:28628672 isoprenaline increases expression ISO Scara5 (Mus musculus) 6480464 Isoproterenol results in increased expression of SCARA5 mRNA CTD PMID:20003209 L-methionine multiple interactions ISO Scara5 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SCARA5 mRNA CTD PMID:20938992 lipopolysaccharide increases expression ISO Scara5 (Mus musculus) 6480464 Lipopolysaccharides results in increased expression of SCARA5 mRNA CTD PMID:27339419 manganese(II) chloride decreases expression EXP 6480464 manganese chloride results in decreased expression of SCARA5 mRNA CTD PMID:28801915 methapyrilene affects methylation ISO SCARA5 (Homo sapiens) 6480464 Methapyrilene affects the methylation of SCARA5 intron CTD PMID:30157460 methapyrilene decreases expression EXP 6480464 Methapyrilene results in decreased expression of SCARA5 mRNA CTD PMID:30467583 methimazole decreases expression EXP 6480464 Methimazole results in decreased expression of SCARA5 mRNA CTD PMID:30047161 N-methyl-4-phenylpyridinium decreases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of SCARA5 mRNA CTD PMID:28801915 N-nitrosodiethylamine multiple interactions ISO Scara5 (Mus musculus) 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of SCARA5 mRNA CTD PMID:24535843 nitrofen increases expression EXP 6480464 nitrofen results in increased expression of SCARA5 mRNA CTD PMID:33484710 ozone multiple interactions ISO Scara5 (Mus musculus) 6480464 [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of SCARA5 mRNA CTD PMID:27106289 paracetamol affects expression ISO Scara5 (Mus musculus) 6480464 Acetaminophen affects the expression of SCARA5 mRNA CTD PMID:17562736 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of SCARA5 mRNA CTD PMID:33387578 paracetamol decreases expression ISO SCARA5 (Homo sapiens) 6480464 Acetaminophen results in decreased expression of SCARA5 mRNA CTD PMID:22230336 perfluorooctane-1-sulfonic acid multiple interactions ISO Scara5 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of SCARA5 mRNA and [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of SCARA5 mRNA CTD PMID:36331819 phenobarbital decreases expression ISO Scara5 (Mus musculus) 6480464 Phenobarbital results in decreased expression of SCARA5 mRNA CTD PMID:19482888 phenobarbital affects expression ISO Scara5 (Mus musculus) 6480464 Phenobarbital affects the expression of SCARA5 mRNA CTD PMID:23091169 phenobarbital multiple interactions ISO Scara5 (Mus musculus) 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of SCARA5 mRNA CTD PMID:24535843 pirinixic acid multiple interactions ISO Scara5 (Mus musculus) 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of SCARA5 mRNA CTD PMID:19710929 pirinixic acid increases expression ISO Scara5 (Mus musculus) 6480464 pirinixic acid results in increased expression of SCARA5 mRNA CTD PMID:18445702 pregnenolone 16alpha-carbonitrile increases expression ISO Scara5 (Mus musculus) 6480464 Pregnenolone Carbonitrile results in increased expression of SCARA5 mRNA CTD PMID:28903501 resveratrol multiple interactions ISO Scara5 (Mus musculus) 6480464 Resveratrol inhibits the reaction [titanium dioxide results in decreased expression of SCARA5 mRNA] CTD PMID:31298478 silicon dioxide decreases expression ISO SCARA5 (Homo sapiens) 6480464 Silicon Dioxide analog results in decreased expression of SCARA5 mRNA CTD PMID:25895662 silicon dioxide increases expression ISO Scara5 (Mus musculus) 6480464 Silicon Dioxide results in increased expression of SCARA5 mRNA CTD PMID:23221170 sodium arsenite increases expression ISO Scara5 (Mus musculus) 6480464 sodium arsenite results in increased expression of SCARA5 mRNA CTD PMID:37682722 streptozocin multiple interactions ISO Scara5 (Mus musculus) 6480464 [Streptozocin co-treated with Dietary Fats] results in increased expression of SCARA5 mRNA and Diethylhexyl Phthalate inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in increased expression of SCARA5 mRNA] CTD PMID:33484791 sulfadimethoxine decreases expression EXP 6480464 Sulfadimethoxine results in decreased expression of SCARA5 mRNA CTD PMID:30047161 sulforaphane increases expression ISO Scara5 (Mus musculus) 6480464 sulforaphane results in increased expression of SCARA5 mRNA CTD PMID:30529165 tamoxifen affects expression ISO Scara5 (Mus musculus) 6480464 Tamoxifen affects the expression of SCARA5 mRNA CTD PMID:20937368 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of SCARA5 mRNA CTD PMID:31150632 tetrachloromethane increases expression ISO Scara5 (Mus musculus) 6480464 Carbon Tetrachloride results in increased expression of SCARA5 mRNA CTD PMID:31919559 titanium dioxide decreases expression ISO Scara5 (Mus musculus) 6480464 titanium dioxide results in decreased expression of SCARA5 mRNA CTD PMID:23557971 and PMID:31298478 titanium dioxide multiple interactions ISO Scara5 (Mus musculus) 6480464 Resveratrol inhibits the reaction [titanium dioxide results in decreased expression of SCARA5 mRNA] CTD PMID:31298478 tributylstannane decreases expression ISO Scara5 (Mus musculus) 6480464 tributyltin results in decreased expression of SCARA5 mRNA CTD PMID:31939706 trimellitic anhydride decreases expression ISO Scara5 (Mus musculus) 6480464 trimellitic anhydride results in decreased expression of SCARA5 mRNA CTD PMID:19042947 valproic acid affects expression ISO SCARA5 (Homo sapiens) 6480464 Valproic Acid affects the expression of SCARA5 mRNA CTD PMID:25979313 valproic acid increases expression ISO SCARA5 (Homo sapiens) 6480464 Valproic Acid results in increased expression of SCARA5 mRNA CTD PMID:28001369